Document Security Systems (DSS) Stock Price, Quote & News

Company Profile

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the adva...

Industry: Packaging & Containers

Sector: Consumer Cyclical

Phone: 585 325 3610

Website: www.dssworld.com

Address:

275 Wiregrass Parkway, West Henrietta, United States

johannn Jan. 14 at 9:47 PM

$DSS And the theft continues and continues, and the real payers see their value plummet. Are you, SEC, blind or just plain stupid to let these scams continue? https://www.sec.gov/Archives/edgar/data/771999/000149315226002268/formpre14c.htm

0 · Reply

SuperGreenToday Jan. 10 at 3:52 AM

$DSS

0 · Reply

OfficialStocktwitsUser Jan. 7 at 1:14 AM

$DSS RSI: 45.83, MACD: -0.0303 Vol: 0.03, MA20: 0.98, MA50: 1.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

johannn Jan. 1 at 2:56 PM

$PRPH $DSS $IBO And two more similarities: DSS wants to receive as much money as possible for its 92,980,843 worthless shares, just as Ted is trying to sell worthless shares on thin air.Impact Bio also rose 50% on December 19th for no reason other than to attract fortune seekers by getting on their radar with large percentage increases. And Impact Biomedical is also supposedly engaged in a reverse merger with another Indian fraud firm that has already robbed small investors several times. The French/Luxembourg-listed firm that wants to do the reverse merger with Prophase seems more reliable and has experience with reverse mergers, as they also acquired their French listing, but I suspect that small investors will receive little from Ted's many promises.

1 · Reply

johannn Jan. 1 at 2:34 PM

$PRPH $DSS $IBO WestPark Capital, Inc. and Equiniti Trust Company LLC. are also the fraud firms that channel the fraud for Prophase and Impact Biomedical, ensuring that small investors are defrauded to the maximum extent possible. And the SEC lets it all happen. 🕵️‍♂️🕵️‍♂️🥷🥷👨‍🦯👨‍🦯 https://www.sec.gov/Archives/edgar/data/1834105/000149315225029621/formdef14c.htm https://www.sec.gov/Archives/edgar/data/868278/000149315225029417/form424b5.htm

0 · Reply

johannn Dec. 31 at 11:33 PM

$IBO $DSS $PRPH Impact Biomedical's reverse stock split is being prepared, and we're not allowed to vote, and my shares are still untradeable. Beware of a pump-and-dump like at Prophase Labs, because DSS Inc. wants to sell/dump another 90+ million worthless shares to you at a high price. https://www.sec.gov/Archives/edgar/data/1834105/000149315225029621/formdef14c.htm

0 · Reply

Render80 Dec. 30 at 7:58 PM

$IBO $DSS For clarity to investors: I am the inventor of the core technologies associated with Impact BioMedical. The company terminated its agreement with me just before the IPO while retaining the technology. I am actively pursuing return of my IP.

1 · Reply

johannn Dec. 19 at 10:31 PM

$PRPH $IBO $DSS Another scam stock that does "business" with Prophase and has risen much more... https://stocktwits.com/symbol/IBO

0 · Reply

johannn Dec. 5 at 8:11 PM

$IBO $DSS So you're essentially doing a Taylor Swift thing—her intellectual property was also stolen, so she re-recorded all the music, but much better. You have the pieces and know how to solve them, but the scammers know nothing. https://www.youtube.com/watch?v=nFHQTOO1ibc&list=RDnFHQTOO1ibc&start_radio=1

0 · Reply

Render80 Dec. 5 at 7:23 PM

$IBO $DSS I am the inventor of the core technologies and developed the central components of the portfolio previously associated with Impact Biomedical. These technologies form the foundation of their past R&D efforts and any subsequent product claims. I have formally issued notices contesting aspects of earlier IP arrangements related to this portfolio. To date, these notices and the existence of the challenges do not appear in current SEC filings, which investors should be aware of. This statement is intended solely to clarify the status of the intellectual property and my contributions to the underlying technologies.

0 · Reply

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

Feb 26, 2025, 8:30 AM EST - 11 months ago

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Feb 3, 2025, 8:50 AM EST - 1 year ago

DSS, Inc. Issues Letter to Shareholders

Jan 15, 2025, 9:35 AM EST - 1 year ago

LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals

Sep 16, 2024, 4:26 PM EDT - 1 year ago

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

Sep 10, 2024, 9:00 AM EDT - 1 year ago

AmericaFirst Funds Trust Announces Changes to Board of Trustees

Aug 26, 2024, 4:08 PM EDT - 1 year ago

DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

Jan 30, 2024, 8:05 AM EST - 2 years ago

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

Jan 4, 2024, 8:15 AM EST - 2 years ago

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

Dec 22, 2023, 4:30 PM EST - 2 years ago

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

Nov 28, 2023, 8:10 AM EST - 2 years ago

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Nov 8, 2023, 8:31 AM EST - 2 years ago

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock

Oct 26, 2023, 5:25 PM EDT - 2 years ago

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

Oct 23, 2023, 8:25 AM EDT - 2 years ago

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

Oct 12, 2023, 8:25 AM EDT - 2 years ago

DSS Inc. Issues Letter to Shareholders

Sep 6, 2023, 8:40 AM EDT - 2 years ago

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

Jul 31, 2023, 8:15 AM EDT - 2 years ago

DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

Jul 5, 2023, 8:15 AM EDT - 2 years ago

DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

Jun 30, 2023, 9:34 AM EDT - 2 years ago

DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

Jun 26, 2023, 8:20 AM EDT - 2 years ago

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

May 16, 2023, 9:00 AM EDT - 2 years ago

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 1, 2023, 8:25 AM EDT - 2 years ago

DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders

Apr 19, 2023, 9:08 AM EDT - 2 years ago

DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders

Apr 17, 2023, 10:00 AM EDT - 3 years ago

DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM

Mar 2, 2023, 8:30 AM EST - 3 years ago

DSS Announces Letter to Shareholders

Aug 30, 2022, 4:45 PM EDT - 3 years ago

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

Jul 21, 2022, 5:00 PM EDT - 3 years ago

DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs

Jul 13, 2022, 8:00 AM EDT - 3 years ago

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

Jun 28, 2022, 8:00 AM EDT - 3 years ago

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

Jun 7, 2022, 7:00 AM EDT - 3 years ago

DSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

May 6, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Feb 28, 2022, 5:15 PM EST - 4 years ago

CORRECTION - DSS Announces Letter to Shareholders

Feb 22, 2022, 5:00 PM EST - 4 years ago

DSS to Present at Aegis Virtual Conference

Jan 25, 2022, 4:30 PM EST - 4 years ago

DSS Receives $17 Million Investment from Alset EHome International

Jan 19, 2022, 3:57 PM EST - 4 years ago

DSS Shareholder Alset EHome To Raise Stake To 55.52%

Jan 19, 2022, 12:13 PM EST - 4 years ago

DSS Acquires 25.1% of Alset International Limited

Jan 12, 2022, 8:30 AM EST - 4 years ago

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

Jan 11, 2022, 10:00 AM EST - 4 years ago

Impact BioMedical Announces New Bioplastics Test Results

Dec 22, 2021, 7:30 AM EST - 4 years ago

DSS Provides Update on Expansion of Premier Packaging Subsidiary

Dec 20, 2021, 10:10 AM EST - 4 years ago

DSS's American Pacific Bancorp Approaches $20M in New Loans Issued

Dec 15, 2021, 7:30 AM EST - 4 years ago

DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds

Dec 7, 2021, 7:30 AM EST - 4 years ago

DSS to Present at the Emerging Growth Conference on December 8

Nov 30, 2021, 7:30 AM EST - 4 years ago

DSS Enters Quantitative Investment Fund Arena

Nov 4, 2021, 9:00 AM EDT - 4 years ago

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

Sep 20, 2021, 7:30 AM EDT - 4 years ago

Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoing Business Expansions

Sep 9, 2021, 7:00 AM EDT - 4 years ago

Alset EHome International Inc.'s American Pacific Bancorp Subsidiary Receives USD $40 Million Investment from Document Security Systems, Inc.

AEI

Aug 23, 2021, 1:52 PM EDT - 4 years ago

DSS Subsidiary Impact Biomedical Reports Positive Test Results For 3FDB DEET Booster Technology

Aug 23, 2021, 9:00 AM EDT - 4 years ago

DSS's Impact BioMedical Reports Positive Test Results for its 3FDB “DEET Booster” Technology

Aug 17, 2021, 12:46 PM EDT - 4 years ago

Document Security Systems Names Todd Macko Finance Chief

Aug 2, 2021, 3:37 PM EDT - 4 years ago

Document Security Systems Invests $1M In Vivacitas Oncology

johannn Jan. 14 at 9:47 PM

0 · Reply

SuperGreenToday Jan. 10 at 3:52 AM

$DSS

0 · Reply

OfficialStocktwitsUser Jan. 7 at 1:14 AM

0 · Reply

johannn Jan. 1 at 2:56 PM

1 · Reply

johannn Jan. 1 at 2:34 PM

0 · Reply

johannn Dec. 31 at 11:33 PM

0 · Reply

Render80 Dec. 30 at 7:58 PM

1 · Reply

johannn Dec. 19 at 10:31 PM

$PRPH $IBO $DSS Another scam stock that does "business" with Prophase and has risen much more... https://stocktwits.com/symbol/IBO

0 · Reply

johannn Dec. 5 at 8:11 PM

0 · Reply

Render80 Dec. 5 at 7:23 PM

0 · Reply

Render80 Dec. 5 at 7:01 PM

$IBO $DSS For anyone tracking Impact Biomedical’s past collaborations: I’ve completed a full rebuild of my scientific portfolio, including upgraded versions of technologies previously associated with them—Equivir, Linebacker, antivirals, repellents, and more. These systems are new, materially different, and outside the scope of prior patents. I have also issued formal notices regarding certain earlier IP arrangements. My updated portfolio will be detailed in upcoming scientific and media releases, giving the public clear visibility. This is a factual update, not investment advice.

0 · Reply

johannn Dec. 5 at 12:13 AM

$AEI $DSS $IBO $HWH The scammers have voted for themselves again. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001750106/000149315225026190/form8-k.htm SEC, where are you? Someone will come up with a solution like this. An old Chinese technique, the thousand-knife slash, which is very suitable for Frank, Jason, and Chan, who are known for their old scamming techniques that they use again and again. Unfortunately, the slash technique has fallen out of fashion. https://www.quora.com/profile/Dilaw-Dalima/Thousand-Knife-Slash

1 · Reply

johannn Nov. 14 at 9:24 PM

$DSS https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=319583135&type=PDF&symbol=DSS&cdn=7378bbc6bcd0fad43ead9c99f3fa504b&companyName=DSS+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2025-11-14

0 · Reply

NoEmotionzTrade Nov. 14 at 4:48 PM

All eyes on TRUG , A+ dip entry here. $PW $JTAI $VEEE $DSS

0 · Reply

johannn Nov. 10 at 10:42 AM

$IBO $DSS $AEI Just a warning: the scammers will be pimping the quarterly figures for both DSS and AEI, presenting the now tradable 90+ million IBO shares as tradable shares in a sister company. These 90+ million shares, which have been added as outstanding IBO shares and therefore have no added value, are essentially worthless and certainly not the value currently indicated on the stock exchange being $0.5505 today 11 November, because that would mean these shares would be worth $49.5 million, which is, of course, ridiculous. 🕵🕵️‍♀️🥷🥷 As of August 5, 2025 there were 12,185,412 shares of the registrant’s common stock, $0.001 par value, outstanding. As of October 27, 2025 there were 104,621,231 shares of the registrant’s common stock, $0.001 par value, outstanding.

1 · Reply

WildChase1 Nov. 8 at 6:11 AM

$DSS .

0 · Reply

johannn Nov. 7 at 10:18 PM

$IBO $DSS $AEI Just to show the dilution that was secretly implemented.... As of October 27, 2025, there were 104,621,231 shares of the registrant's common stock, $0.001 par value, outstanding.https://www.sec.gov/Archives/edgar/data/1834105/000149315225021286/form10-q.htm So, the 60+ million that DSS still had on the shelf, and given the projected Note Payable balance of $14,989,876 and a 10-day VWAP of $0.46931688, the Lender would agree to accept 31,939,778 shares in the Company for settlement of the Note Payable on September 1, 2025. And the rubbish that had already been distributed results in a lot of shares that are worthless or will certainly become worthless soon. Unfortunately, my shares are still blocked.

1 · Reply

johannn Nov. 7 at 9:57 PM

$IBO $DSS $AEI The quarterly figures for this empty shell, Impact Biomedical, are, of course, also showing dramatic losses. They are truly top executives who can repeatedly incur losses. This too will not happen because that other fraudulent company, Prophase, is broke and practically doomed. Equivir/Equivir G is licensed to ProPhase Laboratories for development and commercialization worldwide. So Impact Bio will produce nothing but empty talk and show losses. And hopefully, they'll lose the stolen patents as well. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001834105/000149315225021286/form10-q.htm

1 · Reply

johannn Nov. 6 at 9:53 PM

$IBO $DSS The scammers voted for themselves again and we didn't have to vote anymore. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001834105/000149315225021066/form8-k.htm

0 · Reply

johannn Nov. 5 at 12:44 PM

$AEI $DSS $IBO As expected, the quarter results of a new empty shell "company" are again very dramatic. The former LiquidValue Development Inc., the real estate arm of Alset, is now a loss-making, empty shell restaurant called Winning Catering Group, Inc. Chan is the worst entrepreneur in the world. Oh yeah, I forgot. He's just a dirty, filthy con man who really belongs behind bars. https://www.sec.gov/Archives/edgar/data/1503658/000149315225020765/form10-q.htm

0 · Reply

johannn Nov. 4 at 4:14 PM

$IBO $DSS Very well, then mine will be released soon too; may I ask which part of the world you live in? I live in Belgium/Europe. DSS wants to throw another 60+ million shares on the market, it would be completely criminal if our shares were still blocked and DSS dumped another 60+ million worthless shares on the American criminal market.🥷🥷🕵️🕵️

1 · Reply

johannn Nov. 2 at 8:38 PM

$IBO $DSS Saxo Group 02-Nov-2025 20:20 Dear Mr. Nordhausen, Thank you for your patience and understanding. We would like to inform you that your inquiry is currently being processed by the relevant department. We are actively working on it and have sent a reminder to monitor progress. As soon as we have more information, we will let you know immediately. Should you have any questions or require further clarification in the meantime, please do not hesitate to contact us. We are always ready to assist you. Sincerely, Hande Sencan

1 · Reply

Market Cap	9.12M
Revenue (ttm)	19.10M
Net Income (ttm)	-46.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-245.55%
Debt to Equity Ratio	1.92

Volume	8,400
Avg Vol	11,092
Day's Range	N/A - N/A
Shares Out	9.09M
Stochastic %K	54%
Beta	1.33
Analysts	Strong Sell
Price Target	$3.00